Whole-brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism.

3D magnetic resonance spectroscopic imaging deuterium metabolic imaging deuterium‐labeled glucose downstream neurotransmitter synthesis whole‐brain metabolic mapping

Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 Apr 2024
Historique:
revised: 13 03 2024
received: 27 01 2024
accepted: 04 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: ppublish

Résumé

Deuterium metabolic imaging (DMI) is an emerging magnetic resonance technique, for non-invasive mapping of human brain glucose metabolism following oral or intravenous administration of deuterium-labeled glucose. Regional differences in glucose metabolism can be observed in various brain pathologies, such as Alzheimer's disease, cancer, epilepsy or schizophrenia, but the achievable spatial resolution of conventional phase-encoded DMI methods is limited due to prolonged acquisition times rendering submilliliter isotropic spatial resolution for dynamic whole brain DMI not feasible. The purpose of this study was to implement non-Cartesian spatial-spectral sampling schemes for whole-brain

Identifiants

pubmed: 38647048
doi: 10.1002/hbm.26686
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26686

Subventions

Organisme : NIH HHS
ID : R01EB031787
Pays : United States
Organisme : Wellcome Trust
ID : 225924/Z/22/Z
Pays : United Kingdom

Informations de copyright

© 2024 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

Almuhaideb, A., Papathanasiou, N., & Bomanji, J. (2011). 18F‐FDG PET/CT imaging in oncology. Annals of Saudi Medicine, 31(1), 3–13.
Bednarik, P., Goranovic, D., Svatkova, A., Niess, F., Hingerl, L., Strasser, B., Deelchand, D. K., Spurny‐Dworak, B., Krssak, M., Trattnig, S., Hangel, G., Scherer, T., Lanzenberger, R., & Bogner, W. (2023). (1)H magnetic resonance spectroscopic imaging of deuterated glucose and of neurotransmitter metabolism at 7 T in the human brain. Nature Biomedical Engineering, 7(8), 1001–1013.
Chiew, M., Jiang, W., Burns, B., Larson, P., Steel, A., Jezzard, P., Albert Thomas, M., & Emir, U. E. (2018). Density‐weighted concentric rings k‐space trajectory for (1) H magnetic resonance spectroscopic imaging at 7 T. NMR in Biomedicine, 31(1), e3838.
Clarke, W. T., & Chiew, M. (2022). Uncertainty in denoising of MRSI using low‐rank methods. Magnetic Resonance in Medicine, 87(2), 574–588.
Clarke, W. T., Hingerl, L., Strasser, B., Bogner, W., Valkovic, L., & Rodgers, C. T. (2023). Three‐dimensional, 2.5‐minute, 7T phosphorus magnetic resonance spectroscopic imaging of the human heart using concentric rings. NMR in Biomedicine, 36(1), e4813.
Cocking, D., Damion, R. A., Franks, H., Jaconelli, M., Wilkinson, D., Brook, M., Auer, D. P., & Bowtell, R. (2023). Deuterium brain imaging at 7T during D(2) O dosing. Magnetic Resonance in Medicine, 89(4), 1514–1521.
Crameri, F., Shephard, G. E., & Heron, P. J. (2020). The misuse of colour in science communication. Nature Communications, 11(1), 5444.
De Feyter, H. M., Behar, K. L., Corbin, Z. A., Fulbright, R. K., Brown, P. B., McIntyre, S., Nixon, T. W., Rothman, D. L., & de Graaf, R. A. (2018). Deuterium metabolic imaging (DMI) for MRI‐based 3D mapping of metabolism in vivo. Science Advances, 4(8), eaat7314.
de Graaf, R. A., Pan, J. W., Telang, F., Lee, J. H., Brown, P., Novotny, E. J., Hetherington, H. P., & Rothman, D. L. (2001). Differentiation of glucose transport in human brain gray and white matter. Journal of Cerebral Blood Flow and Metabolism, 21(5), 483–492.
de Graaf, R. A., Thomas, M. A., Behar, K. L., & De Feyter, H. M. (2021). Characterization of kinetic isotope effects and label loss in deuterium‐based isotopic labeling studies. ACS Chemical Neuroscience, 12(1), 234–243.
de Winter, J. C. F. (2013). Using the Student's t‐test with extremely small sample sizes. Practical Assessment, Research, and Evaluation, 18(10).
Dienel, G. A. (2019). Brain glucose metabolism: Integration of energetics with function. Physiological Reviews, 99(1), 949–1045.
Furuyama, J. K., Wilson, N. E., & Thomas, M. A. (2012). Spectroscopic imaging using concentrically circular echo‐planar trajectories in vivo. Magnetic Resonance in Medicine, 67(6), 1515–1522.
Gasparovic, C., Song, T., Devier, D., Bockholt, H. J., Caprihan, A., Mullins, P. G., Posse, S., Jung, R. E., & Morrison, L. A. (2006). Use of tissue water as a concentration reference for proton spectroscopic imaging. Magnetic Resonance in Medicine, 55(6), 1219–1226.
Goryawala, M. Z., Sheriff, S., & Maudsley, A. A. (2016). Regional distributions of brain glutamate and glutamine in normal subjects. NMR in Biomedicine, 29(8), 1108–1116.
Hahn, A., Gryglewski, G., Nics, L., Hienert, M., Rischka, L., Vraka, C., Sigurdardottir, H., Vanicek, T., James, G. M., Seiger, R., Kautzky, A., Silberbauer, L., Wadsak, W., Mitterhauser, M., Hacker, M., Kasper, S., & Lanzenberger, R. (2016). Quantification of task‐specific glucose metabolism with constant infusion of 18F‐FDG. Journal of Nuclear Medicine, 57(12), 1933–1940.
Hangel, G., Cadrien, C., Lazen, P., Furtner, J., Lipka, A., Heckova, E., Hingerl, L., Motyka, S., Gruber, S., Strasser, B., Kiesel, B., Mischkulnig, M., Preusser, M., Roetzer, T., Wohrer, A., Widhalm, G., Rossler, K., Trattnig, S., & Bogner, W. (2020). High‐resolution metabolic imaging of high‐grade gliomas using 7T‐CRT‐FID‐MRSI. NeuroImage: Clinical, 28, 102433.
Hawkins, R. A., Mans, A. M., Davis, D. W., Hibbard, L. S., & Lu, D. M. (1983). Glucose availability to individual cerebral structures is correlated to glucose metabolism. Journal of Neurochemistry, 40(4), 1013–1018.
Heckova, E., Dal‐Bianco, A., Strasser, B., Hangel, G. J., Lipka, A., Motyka, S., Hingerl, L., Rommer, P. S., Berger, T., Hnilicova, P., Kantorova, E., Leutmezer, F., Kurca, E., Gruber, S., Trattnig, S., & Bogner, W. (2022). Extensive brain pathologic alterations detected with 7.0‐T MR spectroscopic imaging associated with disability in multiple sclerosis. Radiology, 303(1), 141–150.
Heckova, E., Strasser, B., Hangel, G. J., Povazan, M., Dal‐Bianco, A., Rommer, P. S., Bednarik, P., Gruber, S., Leutmezer, F., Lassmann, H., Trattnig, S., & Bogner, W. (2019). 7 T magnetic resonance spectroscopic imaging in multiple sclerosis: How does spatial resolution affect the detectability of metabolic changes in brain lesions? Investigative Radiology, 54(4), 247–254.
Heikkila, O., Makimattila, S., Timonen, M., Groop, P. H., Heikkinen, S., & Lundbom, N. (2010). Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes. Cerebellum, 9(3), 336–344.
Hingerl, L., Bogner, W., Moser, P., Povazan, M., Hangel, G., Heckova, E., Gruber, S., Trattnig, S., & Strasser, B. (2018). Density‐weighted concentric circle trajectories for high resolution brain magnetic resonance spectroscopic imaging at 7T. Magnetic Resonance in Medicine, 79(6), 2874–2885.
Hingerl, L., Strasser, B., Moser, P., Hangel, G., Motyka, S., Heckova, E., Gruber, S., Trattnig, S., & Bogner, W. (2020). Clinical high‐resolution 3D‐MR spectroscopic imaging of the human brain at 7 T. Investigative Radiology, 55(4), 239–248.
Jafari, M., & Ansari‐Pour, N. (2019). Why, when and how to adjust your P values? Cell Journal, 20(4), 604–607.
Jenkinson, M., Beckmann, C. F., Behrens, T. E., Woolrich, M. W., & Smith, S. M. (2012). FSL. Neuroimage, 62(2), 782–790.
Jiang, W., Lustig, M., & Larson, P. E. (2016). Concentric rings K‐space trajectory for hyperpolarized (13)C MR spectroscopic imaging. Magnetic Resonance in Medicine, 75(1), 19–31.
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011). Otto Warburg's contributions to current concepts of cancer metabolism. Nature Reviews. Cancer, 11(5), 325–337.
Kreis, R. (2016). The trouble with quality filtering based on relative Cramer‐Rao lower bounds. Magnetic Resonance in Medicine, 75(1), 15–18.
Landheer, K., & Juchem, C. (2021). Are Cramer‐Rao lower bounds an accurate estimate for standard deviations in in vivo magnetic resonance spectroscopy? NMR in Biomedicine, 34(7), e4521.
Li, Y., Zhao, Y., Guo, R., Wang, T., Zhang, Y., Chrostek, M., Low, W. C., Zhu, X. H., Liang, Z. P., & Chen, W. (2021). Machine learning‐enabled high‐resolution dynamic deuterium MR spectroscopic imaging. IEEE Transactions on Medical Imaging, 40(12), 3879–3890.
Lin, A., Andronesi, O., Bogner, W., Choi, I. Y., Coello, E., Cudalbu, C., Juchem, C., Kemp, G. J., Kreis, R., Krssak, M., Lee, P., Maudsley, A. A., Meyerspeer, M., Mlynarik, V., Near, J., Oz, G., Peek, A. L., Puts, N. A., Ratai, E. M., … Experts' Working Group on Reporting Standards for MRS. (2021). Minimum reporting standards for in vivo magnetic resonance spectroscopy (MRSinMRS): Experts' consensus recommendations. NMR in Biomedicine, 34(5), e4484.
Lingala, S. G., Hu, Y., DiBella, E., & Jacob, M. (2011). Accelerated dynamic MRI exploiting sparsity and low‐rank structure: k‐t SLR. IEEE Transactions on Medical Imaging, 30(5), 1042–1054.
Lipka, A., Bogner, W., Dal‐Bianco, A., Hangel, G. J., Rommer, P. S., Strasser, B., Motyka, S., Hingerl, L., Berger, T., Leutmezer, F., Gruber, S., Trattnig, S., & Niess, E. (2023). Metabolic insights into iron deposition in relapsing‐remitting multiple sclerosis via 7 T magnetic resonance spectroscopic imaging. NeuroImage: Clinical, 40, 103524.
Lu, M., Zhu, X. H., Zhang, Y., Mateescu, G., & Chen, W. (2017). Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy. Journal of Cerebral Blood Flow and Metabolism, 37(11), 3518–3530.
Lustig, M., Donoho, D., & Pauly, J. M. (2007). Sparse MRI: The application of compressed sensing for rapid MR imaging. Magnetic Resonance in Medicine, 58(6), 1182–1195.
Magistretti, P. J., & Allaman, I. (2015). A cellular perspective on brain energy metabolism and functional imaging. Neuron, 86(4), 883–901.
Manji, H., Kato, T., Di Prospero, N. A., Ness, S., Beal, M. F., Krams, M., & Chen, G. (2012). Impaired mitochondrial function in psychiatric disorders. Nature Reviews: Neuroscience, 13(5), 293–307.
Maudsley, A. A., Domenig, C., Govind, V., Darkazanli, A., Studholme, C., Arheart, K., & Bloomer, C. (2009). Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magnetic Resonance in Medicine, 61(3), 548–559.
Montrazi, E. T., Bao, Q., Martinho, R. P., Peters, D. C., Harris, T., Sasson, K., Agemy, L., Scherz, A., & Frydman, L. (2023). Deuterium imaging of the Warburg effect at sub‐millimolar concentrations by joint processing of the kinetic and spectral dimensions. NMR in Biomedicine, 36(11), e4995.
Naressi, A., Couturier, C., Devos, J. M., Janssen, M., Mangeat, C., de Beer, R., & Graveron‐Demilly, D. (2001). Java‐based graphical user interface for the MRUI quantitation package. Magma, 12(2‐3), 141–152.
Nguyen, H. M., Peng, X., Do, M. N., & Liang, Z. P. (2013). Denoising MR spectroscopic imaging data with low‐rank approximations. IEEE Transactions on Biomedical Engineering, 60(1), 78–89.
Niess, F., Hingerl, L., Strasser, B., Bednarik, P., Goranovic, D., Niess, E., Hangel, G., Krssak, M., Spurny‐Dworak, B., Scherer, T., Lanzenberger, R., & Bogner, W. (2023). Noninvasive 3‐dimensional 1H‐magnetic resonance spectroscopic imaging of human brain glucose and neurotransmitter metabolism using deuterium labeling at 3T: Feasibility and Interscanner reproducibility. Investigative Radiology, 58, 431–437.
Niess, F., Strasser, B., Hingerl, L., Niess, E., Motyka, S., Hangel, G., Krssak, M., Gruber, S., Spurny‐Dworak, B., Trattnig, S., Scherer, T., Lanzenberger, R., & Bogner, W. (2023). Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct ((2)H) and indirect ((1)H) detection of deuterium labeled compounds at 7T and clinical 3T. NeuroImage, 277, 120250.
Norat, P., Soldozy, S., Sokolowski, J. D., Gorick, C. M., Kumar, J. S., Chae, Y., Yagmurlu, K., Prada, F., Walker, M., Levitt, M. R., Price, R. J., Tvrdik, P., & Kalani, M. Y. S. (2020). Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. npj Regenerative Medicine, 5(1), 22.
Pan, J. W., Stein, D. T., Telang, F., Lee, J. H., Shen, J., Brown, P., Cline, G., Mason, G. F., Shulman, G. I., Rothman, D. L., & Hetherington, H. P. (2000). Spectroscopic imaging of glutamate C4 turnover in human brain. Magnetic Resonance in Medicine, 44(5), 673–679.
Peters, D. C., Markovic, S., Bao, Q., Preise, D., Sasson, K., Agemy, L., Scherz, A., & Frydman, L. (2021). Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation. Magnetic Resonance in Medicine, 86(5), 2604–2617.
Rich, L. J., Bagga, P., Wilson, N. E., Schnall, M. D., Detre, J. A., Haris, M., & Reddy, R. (2020). (1)H magnetic resonance spectroscopy of (2)H‐to‐(1)H exchange quantifies the dynamics of cellular metabolism in vivo. Nature Biomedical Engineering, 4(3), 335–342.
Ruhm, L., Avdievich, N., Ziegs, T., Nagel, A. M., De Feyter, H. M., de Graaf, R. A., & Henning, A. (2021). Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution. NeuroImage, 244, 118639.
Ruhm, L., Ziegs, T., Wright, A. M., Mathy, C. S., Murali‐Manohar, S., Dorst, J., Avdievich, N., & Henning, A. (2022). Dynamic observation of 2H labeled compounds in the human brain with 1H versus 2H magnetic resonance spectroscopy at 9.4T. bioRxiv.
Seres Roig, E., De Feyter, H. M., Nixon, T. W., Ruhm, L., Nikulin, A. V., Scheffler, K., Avdievich, N. I., Henning, A., & de Graaf, R. A. (2023). Deuterium metabolic imaging of the human brain in vivo at 7 T. Magnetic Resonance in Medicine, 89(1), 29–39.
Starcuk, Z., Starcukova, J., Strbak, O., & Graveron‐Demilly, D. (2009). Simulation of coupled‐spin systems in the steady‐state free‐precession acquisition mode for fast magnetic resonance (MR) spectroscopic imaging. Measurement Science and Technology, 20(10), 104033.
Steel, A., Chiew, M., Jezzard, P., Voets, N. L., Plaha, P., Thomas, M. A., Stagg, C. J., & Emir, U. E. (2018). Metabolite‐cycled density‐weighted concentric rings k‐space trajectory (DW‐CRT) enables high‐resolution 1 H magnetic resonance spectroscopic imaging at 3‐Tesla. Scientific Reports, 8(1), 7792.
Tsao, J., Boesiger, P., & Pruessmann, K. P. (2003). k‐t BLAST and k‐t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magnetic Resonance in Medicine, 50(5), 1031–1042.
Veltien, A., van Asten, J., Ravichandran, N., de Graaf, R. A., De Feyter, H. M., Oosterwijk, E., & Heerschap, A. (2021). Simultaneous recording of the uptake and conversion of glucose and choline in tumors by deuterium metabolic imaging. Cancers (Basel), 13(16), 4034.
Yu, Y., Herman, P., Rothman, D. L., Agarwal, D., & Hyder, F. (2018). Evaluating the gray and white matter energy budgets of human brain function. Journal of Cerebral Blood Flow and Metabolism, 38(8), 1339–1353.

Auteurs

Fabian Niess (F)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Bernhard Strasser (B)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Lukas Hingerl (L)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Viola Bader (V)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Sabina Frese (S)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

William T Clarke (WT)

Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Anna Duguid (A)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Eva Niess (E)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Stanislav Motyka (S)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Martin Krššák (M)

Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.

Siegfried Trattnig (S)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Institute for Clinical Molecular MRI, Karl Landsteiner Society, St. Pölten, Austria.

Thomas Scherer (T)

Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.

Rupert Lanzenberger (R)

Department of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria.

Wolfgang Bogner (W)

High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Classifications MeSH